STOCK TITAN
  1. Home
  2. Sec-filings
  3. RREVU
  4. [Form 4] RRE Ventures Acquisition Corp. Insider Trading Activity

RRE Ventures (RREVU) president awarded 600K Class B shares and 500K warrants

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RRE Ventures Acquisition Corp. president Jeffrey Douglas Epstein reported awards of warrants and founder shares. He received 500,000 private placement warrants at a purchase price of $1.0000 per warrant, each exercisable for Class A Ordinary Shares at a conversion price of $11.5000.

He was also granted 450,000 Class B Ordinary Shares on March 2, 2026 and a further 150,000 Class B Ordinary Shares on March 18, 2026, bringing his Class B holdings to 600,000 shares. According to the filing, the Class B Ordinary Shares will automatically convert into Class A Ordinary Shares on a one-for-one basis upon the issuer’s initial business combination, or earlier at his option.

Positive

  • None.

Negative

  • None.

Insights

President receives sizable founder shares and private placement warrants as compensation.

The filing shows Jeffrey Douglas Epstein, president of RRE Ventures Acquisition Corp., acquiring 600,000 Class B Ordinary Shares and 500,000 private placement warrants through awards. These are compensation-type grants rather than open-market purchases or sales.

The Class B Ordinary Shares automatically convert into Class A on a one-for-one basis at the initial business combination, while the private placement warrants become exercisable 30 days after that combination at $11.5000 per share. The impact for investors depends on the company’s total share base and future business combination terms, which are not detailed in this data.

Insider Epstein Jeffrey Douglas
Role President
Type Security Shares Price Value
Grant/Award Warrant 500,000 $1.00 $500K
Grant/Award Class B Ordinary Shares 150,000 $0.00 --
Grant/Award Class B Ordinary Shares 450,000 $0.00 --
Holdings After Transaction: Warrant — 500,000 shares (Direct, null); Class B Ordinary Shares — 600,000 shares (Direct, null)
Footnotes (1)
  1. The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. These securities were previously reported on a Form 3 filed by the Reporting Person. The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation.
Private placement warrants granted 500,000 warrants Award on May 1, 2026 at $1.0000 per warrant
Warrant exercise price $11.5000 per share Conversion or exercise price for Class A Ordinary Shares
Class B shares granted (Mar 2, 2026) 450,000 shares Grant/award acquisition at $0.0000 per share
Class B shares granted (Mar 18, 2026) 150,000 shares Additional grant raising Class B holdings to 600,000 shares
Total Class B holdings after latest grant 600,000 shares Class B Ordinary Shares held directly following March 18, 2026 award
Warrant exercisability start 30 days after business combination Private placement warrants become exercisable after initial business combination
Warrant expiration 5 years after business combination Earlier expiration upon liquidation of the issuer
private placement warrants financial
"The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination"
Private placement warrants are tradable coupons given directly to a limited group of investors that let the holder buy a company's shares at a fixed price before a set expiration date. They matter to investors because they can provide extra upside if the stock rises and give companies a way to raise money outside a public offering, but they also can increase the number of shares outstanding (dilution) and therefore affect share value and investor returns.
Class B Ordinary Shares financial
"The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination"
Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.
initial business combination financial
"at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person"
An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.
Form 3 regulatory
"These securities were previously reported on a Form 3 filed by the Reporting Person."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Epstein Jeffrey Douglas
(Last)(First)(Middle)
5355 TOWN CENTER ROAD
(Street)
BOCA RATON FLORIDA 33486
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
RRE Ventures Acquisition Corp. [ RREV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Ordinary Shares(1)03/02/2026A450,000 (1) (1)Class A Ordinary Shares450,000$0450,000(2)D
Class B Ordinary Shares(1)03/18/2026A150,000 (1) (1)Class A Ordinary Shares150,000$0600,000(2)D
Warrant$11.505/01/2026A500,000 (3) (3)Class A Ordinary Shares500,000$1500,000D
Explanation of Responses:
1. The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date.
2. These securities were previously reported on a Form 3 filed by the Reporting Person.
3. The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation.
/s/ Philip Kassin, Attorney-in-Fact05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did RRE Ventures (RREVU) president Jeffrey Douglas Epstein report on this Form 4?

He reported equity awards, not open-market trades. The filing shows grants of 600,000 Class B Ordinary Shares and 500,000 private placement warrants, representing additional potential exposure to Class A Ordinary Shares tied to the company’s future initial business combination structure.

How many warrants did the RRE Ventures president acquire and at what terms?

He acquired 500,000 private placement warrants at a purchase price of $1.0000 per warrant. Each warrant is exercisable for Class A Ordinary Shares at a conversion or exercise price of $11.5000, becoming exercisable 30 days after completion of the issuer’s initial business combination.

What are the details of the Class B Ordinary Shares granted to the RRE Ventures president?

He was granted 450,000 Class B Ordinary Shares on March 2, 2026 and an additional 150,000 on March 18, 2026. These Class B shares automatically convert into Class A Ordinary Shares on a one-for-one basis at the initial business combination or earlier at his option.

Do the Class B Ordinary Shares in RRE Ventures automatically convert into Class A shares?

Yes. The filing states Class B Ordinary Shares automatically convert into Class A Ordinary Shares at the time of the issuer’s initial business combination, or earlier at the reporting person’s option, on a one-for-one basis, subject to adjustment, with no expiration date for this conversion right.

Are the RRE Ventures president’s transactions open-market buys or compensation awards?

They are compensation-type awards. Each transaction is coded “A” for grant, award, or other acquisition, with no open-market purchase or sale codes. The awards include Class B Ordinary Shares at $0.0000 price and private placement warrants purchased for $1.0000 each.

When do the RRE Ventures private placement warrants held by the president become exercisable and expire?

The private placement warrants become exercisable 30 days after completion of the issuer’s initial business combination. They will expire five years after that business combination is completed or earlier if the issuer is liquidated, according to the footnote in the filing.